CNA Stock Cash Flow Statements

CNA Financial Quarterly Cash Flow Statements Chart

Quarterly

Annual

Stock-Based Compensation

CNA Financial Quarterly Cash Flow Statements Table

Quarterly

Annual

Unit: USD	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-09-30	2016-03-31	2015-12-31	2015-09-30	2015-06-30	2015-03-31	2014-12-31	2014-09-30	2014-06-30	2014-03-31	2013-12-31	2013-09-30	2013-06-30	2013-03-31	2012-12-31	2012-09-30	2012-06-30	2012-03-31	2011-12-31	2011-09-30	2011-06-30	2011-03-31	2010-12-31	2010-09-30	2010-06-30	2010-03-31	2009-12-31	2009-09-30	2009-06-30	2009-03-31	2008-06-30	2008-03-31	2007-09-30	2007-06-30	2007-03-31	2006-09-30	2006-06-30	2006-03-31	2005-12-31	2005-09-30	2005-06-30	2005-03-31	2004-12-31	2004-09-30	2004-06-30	2004-03-31	2003-12-31	2003-09-30	2003-06-30	2003-03-31	2002-12-31	2002-09-30	2002-06-30	2002-03-31

cash flows from operating activities
net income	21,000,000	283,000,000	317,000,000	338,000,000	367,000,000	258,000,000	283,000,000	297,000,000	248,000,000	128,000,000	205,000,000	313,000,000	266,000,000	256,000,000	368,000,000	312,000,000	387,000,000	213,000,000	151,000,000	-61,000,000	107,000,000	66,000,000	-70,000,000	178,000,000	138,000,000	233,000,000	198,000,000	213,000,000	267,000,000	13,000,000	221,000,000	272,000,000	194,000,000	250,000,000	-9,000,000	221,000,000	166,000,000	250,000,000	191,000,000	75,000,000	132,000,000	232,000,000	326,000,000	-125,000,000	302,000,000	255,000,000	270,000,000	277,000,000	119,000,000	-185,000,000	181,000,000	187,000,000	174,000,000	217,000,000	296,000,000	311,000,000	239,000,000	229,000,000	-205,000,000	3,000,000	288,000,000	178,000,000	305,000,000	-28,000,000	289,000,000	-125,000,000	174,000,000	-1,760,000,000	70,000,000	83,000,000	45,000,000	-3,000,000	35,000,000	78,000,000
adjustments to reconcile net income to net cash flows from operating activities:
deferred income tax (benefit) expense									-16,000,000	-8,000,000									4,000,000	-37,000,000
trading portfolio activity		5,000,000			2,000,000	-2,000,000	14,000,000	-13,000,000	11,000,000	-12,000,000			7,000,000	-6,000,000	27,000,000	-8,000,000	-7,000,000	-13,000,000	8,000,000	7,000,000	-5,000,000	-3,000,000	0	16,000,000	-12,000,000	13,000,000	0	-1,000,000	-4,000,000	21,000,000	-12,000,000	9,000,000	41,000,000	-48,000,000	-10,000,000	31,000,000	-38,000,000	-6,000,000	9,000,000	1,000,000	-15,000,000	6,000,000	28,000,000	-28,000,000	54,000,000	99,000,000	457,000,000	-479,000,000	-139,000,000	-3,000,000
net investment losses	39,000,000	10,000,000	10,000,000	22,000,000	-6,000,000	38,000,000	32,000,000	35,000,000	33,000,000	96,000,000	59,000,000	11,000,000					-66,000,000	-27,000,000	-69,000,000	216,000,000
equity method investees	-8,000,000	-21,000,000	-47,000,000	-25,000,000	-45,000,000	66,000,000	-35,000,000	6,000,000	15,000,000	51,000,000	32,000,000	152,000,000	-21,000,000	-27,000,000	-93,000,000	14,000,000	-20,000,000	-56,000,000	-30,000,000	98,000,000	9,000,000	262,000,000	68,000,000	175,000,000	43,000,000	-91,000,000	18,000,000	-10,000,000	-57,000,000	132,000,000	-93,000,000	-79,000,000	-60,000,000	-91,000,000	-21,000,000	-60,000,000	61,000,000	-69,000,000	17,000,000	188,000,000	-4,000,000	-104,000,000	-111,000,000	-39,000,000	1,000,000	13,000,000
net amortization of investments	-47,000,000	-48,000,000	-48,000,000	-57,000,000	-51,000,000	-53,000,000	-41,000,000	-46,000,000	-40,000,000	-33,000,000	-30,000,000	-26,000,000	-23,000,000	-17,000,000	-17,000,000	-24,000,000	-16,000,000	-19,000,000	-17,000,000	-15,000,000	-17,000,000	-4,000,000	34,000,000	-4,000,000
depreciation and amortization	16,000,000	17,000,000	18,000,000	16,000,000	29,000,000	16,000,000	16,000,000	12,000,000	13,000,000	13,000,000	12,000,000	13,000,000	13,000,000	14,000,000	13,000,000	14,000,000	14,000,000	15,000,000	15,000,000	16,000,000	16,000,000	21,000,000	22,000,000	23,000,000	20,000,000	19,000,000	21,000,000	20,000,000	22,000,000	20,000,000	21,000,000	22,000,000	25,000,000	33,000,000	42,000,000
changes in:
receivables	-494,000,000	222,000,000	-464,000,000	-162,000,000	-161,000,000	413,000,000	-473,000,000	-24,000,000	164,000,000	224,000,000	-609,000,000	-5,000,000	-282,000,000	11,000,000	-387,000,000	-700,000,000	-138,000,000	315,000,000	-357,000,000	-229,000,000	342,000,000	-317,000,000	12,000,000	281,000,000	-54,000,000	-157,000,000	120,000,000	605,000,000	-120,000,000	126,000,000	-272,000,000	399,000,000	-63,000,000	-20,000,000	-299,000,000	278,000,000	17,000,000	53,000,000	753,000,000	128,000,000	68,000,000	71,000,000	303,000,000	-1,023,000,000	50,000,000	264,000,000	127,000,000	463,000,000	163,000,000	223,000,000	243,000,000	158,000,000	165,000,000	401,000,000	43,000,000	1,275,000,000	-11,000,000	279,000,000	2,350,000,000	63,000,000	982,000,000	316,000,000	32,000,000	480,000,000	-1,148,000,000	197,000,000
accrued investment income	7,000,000	-5,000,000	-6,000,000	-4,000,000	-2,000,000	-18,000,000	-8,000,000	-13,000,000	8,000,000	-31,000,000	16,000,000	-22,000,000	20,000,000	-14,000,000	16,000,000	-19,000,000	22,000,000	-17,000,000	19,000,000	-8,000,000	-11,000,000	-22,000,000	33,000,000	-42,000,000	33,000,000	-25,000,000		-34,000,000	33,000,000	-36,000,000	39,000,000	-36,000,000	30,000,000	-42,000,000	50,000,000	-36,000,000	32,000,000	-42,000,000	25,000,000	-31,000,000	33,000,000	-44,000,000	36,000,000	-42,000,000	32,000,000	-41,000,000	13,000,000	-46,000,000	4,000,000	-31,000,000	34,000,000	-28,000,000	-13,000,000	-5,000,000	-8,000,000	-30,000,000	-17,000,000	33,000,000	5,000,000	-26,000,000	18,000,000	-12,000,000	44,000,000	-24,000,000	-2,000,000	-30,000,000
deferred acquisition costs	-24,000,000	10,000,000	-21,000,000	-34,000,000	-11,000,000	0	-29,000,000	-45,000,000	-13,000,000	-3,000,000	-32,000,000	-31,000,000	-15,000,000	-3,000,000	20,000,000	-32,000,000	-7,000,000	5,000,000	-14,000,000	-27,000,000	10,000,000	-23,000,000	300,000,000	19,000,000	5,000,000	-13,000,000	30,000,000	24,000,000	11,000,000	-21,000,000	25,000,000	20,000,000	-3,000,000	-40,000,000	11,000,000	-10,000,000	-2,000,000	-15,000,000	19,000,000	-1,000,000	-8,000,000	-19,000,000	17,000,000	-1,000,000	14,000,000	-1,000,000	30,000,000	7,000,000	-13,000,000	-7,000,000	-9,000,000	3,000,000	8,000,000	-8,000,000	1,000,000	-9,000,000	-13,000,000	-1,000,000	37,000,000	14,000,000	6,000,000	14,000,000	44,000,000	32,000,000	108,000,000	10,000,000
insurance reserves	806,000,000	304,000,000	812,000,000	443,000,000	483,000,000	19,000,000	733,000,000	432,000,000	48,000,000	367,000,000	887,000,000	489,000,000	572,000,000	518,000,000	768,000,000	605,000,000	202,000,000	298,000,000	671,000,000	510,000,000	134,000,000	511,000,000	46,000,000	-256,000,000	147,000,000	304,000,000	-141,000,000	-456,000,000	149,000,000	85,000,000	98,000,000	-364,000,000	119,000,000	79,000,000	483,000,000	-174,000,000	22,000,000	99,000,000	-232,000,000	-98,000,000	48,000,000	45,000,000	-242,000,000	-126,000,000	-302,000,000	-135,000,000	-124,000,000	-243,000,000	-106,000,000	-139,000,000	-107,000,000	-41,000,000	-186,000,000	-118,000,000	32,000,000	55,000,000	-189,000,000	-181,000,000	-837,000,000	612,000,000	-251,000,000	-467,000,000	168,000,000	-207,000,000	1,170,000,000	-365,000,000
other	473,000,000	-40,000,000	59,000,000	-72,000,000	-75,000,000	100,000,000	9,000,000	-226,000,000	41,000,000	-55,000,000	88,000,000	-266,000,000	108,000,000	-60,000,000	-71,000,000	-53,000,000	4,000,000	52,000,000	57,000,000	-258,000,000	-15,000,000	9,000,000	-94,000,000	10,000,000	63,000,000	19,000,000	86,000,000	40,000,000	-75,000,000	3,000,000			-7,000,000	13,000,000	6,000,000	3,000,000	4,000,000	1,000,000	0	1,000,000	8,000,000	1,000,000	2,000,000	1,000,000	5,000,000	-3,000,000	-1,000,000	1,000,000	-3,000,000	6,000,000			-37,000,000	-53,000,000	6,000,000	-125,000,000	132,000,000	20,000,000	-11,000,000	110,000,000	-251,000,000	36,000,000	-107,000,000	125,000,000	18,000,000	-151,000,000	30,000,000	13,000,000	19,000,000	-14,000,000	198,000,000	-188,000,000	-15,000,000	-7,000,000
net cash flows from operating activities	703,000,000	748,000,000	616,000,000	504,000,000	520,000,000	828,000,000	501,000,000	436,000,000	512,000,000	737,000,000	608,000,000	645,000,000	643,000,000	669,000,000	603,000,000	82,000,000	367,000,000	758,000,000	438,000,000	212,000,000	466,000,000	334,000,000	342,000,000	505,000,000	446,000,000	94,000,000	393,000,000	460,000,000	419,000,000	168,000,000		352,000,000	378,000,000	191,000,000																										190,000,000	720,000,000	124,000,000	348,000,000	576,000,000	646,000,000	37,000,000		1,367,000,000
cash flows from investing activities
dispositions:
fixed maturity securities - sales	458,000,000	724,000,000	875,000,000	736,000,000	745,000,000	999,000,000	871,000,000	1,414,000,000	1,024,000,000	1,592,000,000	2,490,000,000	803,000,000	1,306,000,000	664,000,000	939,000,000	907,000,000	881,000,000	1,250,000,000	2,950,000,000	823,000,000	1,014,000,000	1,722,000,000	800,000,000	731,000,000	1,715,000,000	1,144,000,000	909,000,000	1,086,000,000	1,369,000,000	1,550,000,000	2,039,000,000	1,687,000,000	1,734,000,000	1,409,000,000
fixed maturity securities - maturities, calls and redemptions	641,000,000	646,000,000	602,000,000	507,000,000	374,000,000	347,000,000	296,000,000	317,000,000	263,000,000	380,000,000	799,000,000	916,000,000	1,104,000,000	1,256,000,000	1,020,000,000	1,084,000,000	1,054,000,000	1,084,000,000	823,000,000	799,000,000	742,000,000	490,000,000	994,000,000	797,000,000	1,160,000,000	1,144,000,000	1,082,000,000	947,000,000	1,103,000,000	851,000,000	775,000,000	676,000,000	954,000,000	866,000,000
equity securities	135,000,000	100,000,000	102,000,000	186,000,000	125,000,000	71,000,000	59,000,000	62,000,000	279,000,000	37,000,000	116,000,000	77,000,000	79,000,000	44,000,000	74,000,000	119,000,000	80,000,000	45,000,000	132,000,000	98,000,000	54,000,000	4,000,000	14,000,000	10,000,000	31,000,000	2,000,000	8,000,000	9,000,000	3,000,000	11,000,000	21,000,000	22,000,000	9,000,000	51,000,000																														0	0	4,000,000
limited partnerships	52,000,000	16,000,000	17,000,000	12,000,000	26,000,000	59,000,000	51,000,000	28,000,000	14,000,000	23,000,000	21,000,000	80,000,000	68,000,000	54,000,000	75,000,000	49,000,000	92,000,000	24,000,000	53,000,000	204,000,000	120,000,000	89,000,000	18,000,000	71,000,000	65,000,000	20,000,000	34,000,000	15,000,000	50,000,000	68,000,000	17,000,000	14,000,000	19,000,000	58,000,000																														-14,000,000	49,000,000	419,000,000
mortgage loans	30,000,000	14,000,000	43,000,000	18,000,000	12,000,000	32,000,000	39,000,000	39,000,000	24,000,000	25,000,000	21,000,000	55,000,000	100,000,000	21,000,000	27,000,000	42,000,000	33,000,000	16,000,000	10,000,000	15,000,000	39,000,000	22,000,000	4,000,000	3,000,000	16,000,000	3,000,000	21,000,000	3,000,000	20,000,000	13,000,000	2,000,000	2,000,000	17,000,000	1,000,000
purchases:
fixed maturity securities	-1,388,000,000	-1,678,000,000	-1,717,000,000	-1,621,000,000	-1,157,000,000	-1,953,000,000	-1,248,000,000	-2,258,000,000	-1,053,000,000	-2,517,000,000	-3,704,000,000	-2,547,000,000	-2,180,000,000	-2,512,000,000	-2,412,000,000	-2,203,000,000	-1,803,000,000	-3,110,000,000	-3,538,000,000	-1,818,000,000	-2,157,000,000	-2,238,000,000	-1,620,000,000	-2,026,000,000	-3,110,000,000	-1,919,000,000	-1,908,000,000	-2,536,000,000	-2,849,000,000	-2,072,000,000	-2,992,000,000	-2,549,000,000	-2,936,000,000	-2,720,000,000
change in other investments	-9,000,000	-7,000,000	7,000,000	-2,000,000	-8,000,000	0	8,000,000	-2,000,000	-1,000,000	-6,000,000	18,000,000	-3,000,000	-9,000,000	-3,000,000	8,000,000	-2,000,000	-4,000,000	-2,000,000	4,000,000	-6,000,000	-4,000,000		-1,000,000	-3,000,000	1,000,000	7,000,000	5,000,000	0			-3,000,000			3,000,000	-13,000,000	22,000,000	3,000,000	10,000,000	-4,000,000	-6,000,000	-88,000,000	-43,000,000	-36,000,000	-28,000,000	-148,000,000	-51,000,000	39,000,000	-1,000,000	47,000,000	55,000,000	-28,000,000	-125,000,000	-6,000,000	-52,000,000	-37,000,000	-44,000,000	-9,000,000	-86,000,000	69,000,000	-19,000,000	41,000,000	-5,000,000	179,000,000	-142,000,000	56,000,000	7,000,000	189,000,000	114,000,000	-7,000,000	4,000,000	313,000,000	-83,000,000	-30,000,000	-33,000,000
change in short-term investments	-182,000,000	-132,000,000	269,000,000	192,000,000																																																							2,788,000,000	-1,787,000,000	2,254,000,000	-1,628,000,000		-252,000,000	2,121,000,000	1,820,000,000		-1,705,000,000	54,000,000	1,668,000,000		-1,077,000,000	-849,000,000	532,000,000
purchases of property and equipment	-38,000,000	-18,000,000	-19,000,000	-20,000,000	-23,000,000	-24,000,000	-23,000,000	-20,000,000	-11,000,000	-16,000,000	-13,000,000	-12,000,000	-10,000,000	-11,000,000	-2,000,000	-3,000,000	-7,000,000	-6,000,000	-7,000,000	-3,000,000	-6,000,000	-33,000,000	-41,000,000	-27,000,000	-37,000,000	-20,000,000	-29,000,000	-15,000,000	-17,000,000	-10,000,000	-24,000,000	-25,000,000	-21,000,000	-21,000,000	-34,000,000	-18,000,000	-20,000,000	-22,000,000	-17,000,000	-43,000,000	-13,000,000	-11,000,000	-15,000,000	-15,000,000	-11,000,000	-12,000,000	-17,000,000	-13,000,000	-16,000,000	-17,000,000	-32,000,000	-32,000,000	-31,000,000	-53,000,000	-34,000,000	-29,000,000	-42,000,000	-16,000,000	-17,000,000	-11,000,000	-1,000,000	-16,000,000	-9,000,000	-8,000,000	-13,000,000	-11,000,000	3,000,000	-14,000,000	-23,000,000	-31,000,000	-27,000,000	-25,000,000	-11,000,000	-25,000,000
net cash flows used by investing activities	-555,000,000	-553,000,000			-306,000,000	-679,000,000			-440,000,000	-641,000,000			-631,000,000				-298,000,000						-118,000,000				169,000,000	-353,000,000	-380,000,000	-354,000,000		-218,000,000	-310,000,000	-161,000,000																										-176,000,000	-249,000,000	-115,000,000	-870,000,000				-863,000,000
cash flows from financing activities
dividends paid to common stockholders	-119,000,000	-120,000,000	-119,000,000	-667,000,000	-114,000,000	-114,000,000	-114,000,000	-445,000,000	-108,000,000	-109,000,000	-108,000,000	-657,000,000	-103,000,000	-104,000,000	-104,000,000	-310,000,000	-100,000,000	-100,000,000	-101,000,000	-649,000,000	-96,000,000	-609,000,000	-67,000,000	-68,000,000	-68,000,000	-608,000,000	-68,000,000	-67,000,000	-68,000,000	-338,000,000	-54,000,000	-54,000,000	-53,000,000	-55,000,000	-40,000,000	-41,000,000	-40,000,000	-41,000,000	-27,000,000	-27,000,000	-27,000,000	-27,000,000
proceeds from the issuance of debt	0	0	0	490,000,000	0	96,000,000											0				0	498,000,000					0	0	0	546,000,000									0	0	0	396,000,000	0
repayment of debt	0	0															0				0	-358,000,000									0				0				-31,000,000	-11,000,000	0	-409,000,000
purchase of treasury stock	0	0			0	0	0	-24,000,000	0	-18,000,000	0	-21,000,000	0	0	-15,000,000	-3,000,000	0	0	0	-18,000,000	-2,000,000																														0	-70,000,000
net cash flows used by financing activities	-119,000,000	-120,000,000	-689,000,000	-189,000,000	-359,000,000	-18,000,000	280,000,000	-480,000,000	-108,000,000	-138,000,000	-98,000,000	-688,000,000	-103,000,000	-104,000,000	-120,000,000	-321,000,000	-101,000,000	-25,000,000	-101,000,000	-675,000,000	-99,000,000	-469,000,000										-73,000,000	-71,000,000	-56,000,000																										2,000,000				-1,000,000				-11,000,000	-12,000,000	-137,000,000				-5,000,000
effect of foreign exchange rate changes on cash	-13,000,000	6,000,000	-1,000,000	-2,000,000			3,000,000	1,000,000	8,000,000	-15,000,000	-9,000,000	-3,000,000	2,000,000	-7,000,000					4,000,000	-9,000,000	-5,000,000	-1,000,000	-5,000,000	-4,000,000	4,000,000	-6,000,000	-5,000,000	-5,000,000	1,000,000	1,000,000	0	3,000,000	1,000,000	-7,000,000	1,000,000			1,000,000
net change in cash	16,000,000	81,000,000	-34,000,000	64,000,000	-140,000,000	127,000,000	-125,000,000	8,000,000	-28,000,000	-57,000,000	199,000,000	-175,000,000	-89,000,000	163,000,000	-126,000,000	169,000,000	-23,000,000	-144,000,000	-271,000,000	615,000,000	69,000,000	-145,000,000	151,000,000	91,000,000	-56,000,000	11,000,000	-57,000,000	43,000,000	-2,000,000	11,000,000	10,000,000	64,000,000	-2,000,000	-33,000,000	27,000,000	29,000,000	41,000,000	-16,000,000	-9,000,000	0	3,000,000	4,000,000	-5,000,000	10,000,000	-23,000,000	-45,000,000	12,000,000	30,000,000	4,000,000	9,000,000	-54,000,000	40,000,000	5,000,000	-32,000,000	-10,000,000	4,000,000	31,000,000	-24,000,000	25,000,000	16,000,000	-23,000,000	-2,000,000		-32,000,000	22,000,000	-58,000,000
cash, beginning of year	0	0	0	345,000,000	0	0	0	475,000,000	0	0	0	536,000,000	0	0	0	419,000,000	0	0	0	242,000,000	0	387,000,000	0	0	0	190,000,000	0	0	0	195,000,000	0	0	0	156,000,000	0	0	0	75,000,000	0	0	0	77,000,000	0	0	0	140,000,000	0	0	0	85,000,000	0	101,000,000	0	0	124,000,000	0	0	125,000,000
cash, end of year
years ended december 31
common stock
balance, beginning of year	-1,527,000,000	9,000,000	-20,000,000	2,221,000,000								683,000,000
balance, end of year												683,000,000
additional paid-in capital
stock-based compensation	-3,000,000	2,000,000	29,000,000	-20,000,000	-8,000,000	1,000,000	32,000,000	-24,000,000	-3,000,000	0	28,000,000	-20,000,000	-3,000,000	0	24,000,000	-17,000,000	2,000,000	-3,000,000	25,000,000	-16,000,000	1,000,000
retained earnings
balance, beginning of year, as previously reported
cumulative effect adjustments from changes in accounting guidance, net of tax								-236,000,000												-5,000,000
balance, beginning of year, as adjusted
dividends to common stockholders	-907,000,000	-2,000,000	549,000,000	-668,000,000	-672,000,000	1,000,000	327,000,000	-442,000,000	-875,000,000	-1,000,000	548,000,000	-657,000,000	-516,000,000	0	205,000,000	-309,000,000	-852,000,000	2,000,000	546,000,000	-648,000,000	0
accumulated other comprehensive income
other comprehensive income	-29,000,000	685,000,000	-75,000,000	100,000,000			-407,000,000	290,000,000					-320,000,000	-485,000,000			495,000,000	-967,000,000	2,345,000,000	-1,121,000,000	-425,000,000
treasury stock
total stockholders' equity	-245,000,000	884,000,000	212,000,000	9,662,000,000	1,330,000,000	-163,000,000	59,000,000	8,667,000,000	731,000,000	-1,418,000,000	-1,305,000,000	10,817,000,000	145,000,000	-4,000,000	579,000,000	12,089,000,000	686,000,000	376,000,000	1,283,000,000	10,362,000,000	36,000,000
deferred income tax expense		11,000,000	-8,000,000	39,000,000	-10,000,000	-9,000,000	0	21,000,000				17,000,000	1,000,000	19,000,000	-3,000,000	30,000,000						55,000,000		-5,000,000	-39,000,000	71,000,000	-78,000,000	33,000,000	23,000,000	25,000,000	-64,000,000	19,000,000	23,000,000	99,000,000	52,000,000	14,000,000	8,000,000	73,000,000	39,000,000	55,000,000	8,000,000	90,000,000	164,000,000	81,000,000	37,000,000	45,000,000
cash, end of period		81,000,000	-34,000,000	409,000,000		127,000,000	-125,000,000	483,000,000	-28,000,000	-57,000,000	199,000,000	361,000,000	-89,000,000	163,000,000	-126,000,000	588,000,000	-23,000,000	-144,000,000	-271,000,000	857,000,000	69,000,000	242,000,000		91,000,000	-56,000,000	201,000,000		43,000,000	-2,000,000	206,000,000		64,000,000	-2,000,000	123,000,000		29,000,000	41,000,000	59,000,000		0	3,000,000	81,000,000		10,000,000	-23,000,000	95,000,000		30,000,000	4,000,000	94,000,000	-54,000,000	141,000,000	5,000,000	-32,000,000	114,000,000	4,000,000	31,000,000	101,000,000		16,000,000	-23,000,000	93,000,000		-32,000,000	22,000,000	81,000,000
periods ended september 30
balance, beginning of period		0	0	683,000,000		0	0	683,000,000		0				0	0	683,000,000		0	0	683,000,000	0
balance, end of period		0	0	683,000,000		0	0	683,000,000		0				0	0	683,000,000		0	0	683,000,000	0
balance, beginning of period, as previously reported		198,000,000	-330,000,000	9,755,000,000		168,000,000	-381,000,000	9,572,000,000						264,000,000	3,000,000	9,081,000,000		49,000,000	-714,000,000	9,348,000,000
accumulated other comprehensive loss
periods ended june 30
net cash flows (used) provided by investing activities				-249,000,000								-129,000,000										-9,000,000																																																	-852,000,000	-226,000,000
three months ended march 31																																																		2,009,000,000		2,008,000,000			2,007,000,000
accumulated other comprehensive
change in short term investments						-37,000,000	-743,000,000	681,000,000	-748,000,000	35,000,000	181,000,000	687,000,000	-838,000,000	313,000,000	-131,000,000	573,000,000	-442,000,000	-6,000,000	-858,000,000	1,267,000,000	31,000,000	16,000,000	-188,000,000	189,000,000	-157,000,000	190,000,000	168,000,000	122,000,000	10,000,000	-688,000,000	68,000,000	64,000,000	29,000,000	264,000,000	498,000,000	-382,000,000	-115,000,000	-8,000,000	67,000,000	-15,000,000	-34,000,000	548,000,000	-123,000,000	963,000,000	-685,000,000	1,474,000,000	133,000,000	435,000,000	146,000,000	-1,041,000,000	266,000,000	-696,000,000	252,000,000	845,000,000	-2,060,000,000	-3,044,000,000	2,677,000,000	-4,014,000,000
balance, beginning of period, as adjusted						168,000,000	-145,000,000	9,336,000,000						264,000,000	3,000,000	9,081,000,000		49,000,000	-709,000,000	9,343,000,000
other comprehensive loss												-1,623,000,000				-616,000,000
net cash flows provided (used) by investing activities								51,000,000																	-439,000,000	526,000,000																																							-101,000,000	-441,000,000
net investment (gains) losses													-3,000,000	-22,000,000	-38,000,000	-57,000,000
net cash flows from investing activities																408,000,000			-612,000,000	1,087,000,000																																																		132,000,000				35,000,000
deferred income tax benefit																	-8,000,000																																80,000,000	-139,000,000	-23,000,000	-21,000,000
net investment gains																					-7,000,000
net realized investment gains																									0	-10,000,000	12,000,000	-38,000,000	13,000,000	-47,000,000		-4,000,000	14,000,000	-28,000,000
other assets																						-89,000,000	-18,000,000	-1,000,000	-26,000,000	-34,000,000	1,000,000	1,000,000	-15,000,000	-35,000,000	35,000,000	7,000,000	-49,000,000	-20,000,000	54,000,000	47,000,000	-30,000,000	73,000,000	65,000,000	73,000,000	41,000,000	-4,000,000	-26,000,000	128,000,000	47,000,000	-7,000,000	119,000,000	-154,000,000	80,000,000	8,000,000	0	-23,000,000	10,000,000	23,000,000	-2,000,000											1,000,000
other liabilities																						-168,000,000	158,000,000	62,000,000	141,000,000	-235,000,000	85,000,000	68,000,000	171,000,000	-372,000,000	292,000,000	99,000,000	118,000,000	16,000,000	-96,000,000	35,000,000	79,000,000	-67,000,000	-6,000,000	-28,000,000	2,000,000	-155,000,000	64,000,000	41,000,000	22,000,000	-74,000,000	38,000,000	-18,000,000	-34,000,000	-125,000,000	-59,000,000	-131,000,000	18,000,000	43,000,000	-178,000,000									-12,000,000	18,000,000	47,000,000
total adjustments																						268,000,000	412,000,000	327,000,000	308,000,000	-139,000,000	195,000,000	247,000,000	152,000,000	155,000,000	62,000,000	80,000,000	184,000,000	-59,000,000	266,000,000	154,000,000	140,000,000	62,000,000	698,000,000	326,000,000	168,000,000	-118,000,000	259,000,000	-1,054,000,000	-76,000,000	114,000,000	720,000,000	-285,000,000	-16,000,000	381,000,000	330,000,000	112,000,000	-11,000,000	114,000,000	-61,000,000	545,000,000	57,000,000	402,000,000	1,387,000,000	187,000,000	432,000,000	-54,000,000	43,000,000	604,000,000	357,000,000	162,000,000					188,000,000
nine months ended september 30
net realized investment losses																						36,000,000
disposals of property and equipment																						107,000,000
loss on sale of subsidiaries																											0
proceeds from sale of subsidiaries																											0
other dispositions
net realized investment (gains) losses
net cash flows provided (used) by financing activities																								-69,000,000	-67,000,000	-603,000,000		-68,000,000	-47,000,000	210,000,000																																-11,000,000				346,000,000
impairment loss on sale of subsidiary
six months ended june 30
transfer of cash to assets held for sale																													5,000,000	-14,000,000
purchase of hardy																																			0
amortization of investments																														-1,000,000	-4,000,000	-6,000,000	-4,000,000	-10,000,000	-12,000,000	-10,000,000	-10,000,000	-23,000,000	-17,000,000	-10,000,000	-16,000,000	-21,000,000	-33,000,000	-25,000,000	-26,000,000	-33,000,000
stock options exercised																												0	0	4,000,000	1,000,000	0	0	1,000,000	0	0			0	0	-4,000,000	6,000,000	7,000,000	3,000,000			0						0	2,000,000	15,000,000
impairment loss on pending sale of subsidiary																													0	255,000,000
income from discontinued operations																																							0														0
loss on disposal of property and equipment																																			3,000,000	0	0	1,000,000	1,000,000	0							1,000,000	5,000,000					-2,000,000	1,000,000	2,000,000		-2,000,000	4,000,000				7,000,000	17,000,000
net cash flows from operating activities-continuing operations																																			257,000,000	375,000,000	306,000,000	312,000,000			300,000,000	114,000,000			226,000,000	369,000,000	990,000,000	-8,000,000	103,000,000	196,000,000	511,000,000	299,000,000	163,000,000	331,000,000	235,000,000	856,000,000	296,000,000	631,000,000
net cash flows used by operating activities-discontinued operations																																							0	0	0	-2,000,000	-1,000,000	-75,000,000	-9,000,000	-5,000,000	-7,000,000						9,000,000	-7,000,000	-18,000,000		1,000,000	-5,000,000
net cash flows from operating activities-total																																				375,000,000	306,000,000	312,000,000			300,000,000	112,000,000			217,000,000	364,000,000	983,000,000	-12,000,000	100,000,000	187,000,000	509,000,000	303,000,000	172,000,000	324,000,000	217,000,000	860,000,000	297,000,000	626,000,000
net cash flows used by investing activities-continuing operations																																						-287,000,000				-76,000,000			-163,000,000	-374,000,000	-932,000,000	48,000,000					-130,000,000	-377,000,000	-202,000,000	-987,000,000	-223,000,000	-304,000,000
net cash flows from investing activities-discontinued operations																																							0	0	0	2,000,000	1,000,000	61,000,000	9,000,000	5,000,000	7,000,000	4,000,000
net cash flows used by investing activities-total																																						-287,000,000				-74,000,000			-154,000,000	-369,000,000	-925,000,000	52,000,000					-138,000,000	-328,000,000	-201,000,000	-987,000,000	-196,000,000	-307,000,000
acquisition of cna surety noncontrolling interest																																							0	-49,000,000
net cash flows used by financing activities-continuing operations																																			-44,000,000	-112,000,000	-41,000,000	-42,000,000	-56,000,000	-84,000,000	-468,000,000	-36,000,000		-121,000,000	-86,000,000	-38,000,000		-13,000,000	-33,000,000	-26,000,000	-321,000,000	-273,000,000	-29,000,000	-28,000,000	-26,000,000	131,000,000	-70,000,000	-343,000,000
net cash flows provided (used) by financing activities-discontinued operations
net cash flows used by financing activities-total																																			-44,000,000	-112,000,000	-41,000,000	-42,000,000	-56,000,000	-84,000,000	-468,000,000	-36,000,000		-121,000,000	-86,000,000	-38,000,000		-13,000,000	-33,000,000	-26,000,000	-321,000,000	-273,000,000	-29,000,000	-28,000,000	-26,000,000	131,000,000	-70,000,000	-343,000,000
adjustments to reconcile net income to net cash flows provided (used) by operating activities:
net realized investment (gains) losses, net of participating policyholders’ interests																																											39,000,000	-62,000,000	-29,000,000	-34,000,000
net cash flows provided (used) by operating activities-discontinued operations																																																	-3,000,000	-9,000,000	-2,000,000	4,000,000
net cash flows provided (used) by operating activities-total																																							889,000,000				584,000,000
net cash flows provided (used) by investing activities-continuing operations																																							-843,000,000	-314,000,000			-94,000,000							-159,000,000		13,000,000
net cash flows provided (used) by investing activities-discontinued operations																																																		9,000,000		-2,000,000			1,000,000			-3,000,000
net cash flows provided (used) by investing activities-total																																							-843,000,000	-314,000,000			-93,000,000							-150,000,000		11,000,000
dividends paid to loews corporation for 2008 senior preferred																																												-18,000,000	-25,000,000	-25,000,000		-31,000,000	-32,000,000	-31,000,000
payment to redeem 2008 senior preferred
net cash transactions from continuing operations to discontinued operations																																											0										-4,000,000			0	-1,000,000	16,000,000
net cash transactions to discontinued operations from continuing operations																																											0
net realized investment gains, net of participating policyholders’ interests																																				-8,000,000	-22,000,000	-36,000,000		27,000,000	-15,000,000	-13,000,000
purchases of fixed maturity securities																																				-2,200,000,000	-2,327,000,000	-2,842,000,000	-3,314,000,000	-2,654,000,000	-2,720,000,000	-3,480,000,000	-3,723,000,000	-3,503,000,000	-4,127,000,000	-5,351,000,000	-6,090,000,000	-5,697,000,000	-5,323,000,000	-7,079,000,000	-17,029,000,000	-11,231,000,000	-19,558,000,000	-18,386,000,000	-15,552,000,000	-9,742,000,000	-12,732,000,000	-9,951,000,000	-16,420,000,000	-12,483,000,000	-21,773,000,000	-12,314,000,000	-14,382,000,000	-13,281,000,000	-16,825,000,000	-14,475,000,000	-13,261,000,000	-14,047,000,000	-16,309,000,000	-17,802,000,000	-13,590,000,000	-17,034,000,000	-18,240,000,000	-14,303,000,000
proceeds from fixed maturity securities:
sales																																				1,458,000,000	1,374,000,000	1,929,000,000	1,679,000,000	1,788,000,000	2,231,000,000	1,881,000,000	3,251,000,000	2,875,000,000	3,651,000,000	2,737,000,000	3,738,000,000	4,424,000,000	4,037,000,000	7,046,000,000	15,998,000,000	10,262,000,000	21,405,000,000	15,163,000,000	16,435,000,000	9,812,000,000	9,433,000,000	11,697,000,000	13,376,000,000	11,358,000,000	18,323,000,000	12,554,000,000	13,037,000,000	12,202,000,000	12,572,000,000	10,867,000,000
maturities, calls and redemptions																																				1,089,000,000	883,000,000	683,000,000	621,000,000	609,000,000	860,000,000	965,000,000	449,000,000	1,025,000,000	1,020,000,000	846,000,000	880,000,000	845,000,000	896,000,000	827,000,000	1,426,000,000	1,038,000,000	884,000,000	1,820,000,000	1,016,000,000	951,000,000	1,074,000,000	1,089,000,000	684,000,000	1,736,000,000	1,168,000,000	991,000,000	1,173,000,000	1,005,000,000	1,308,000,000	1,443,000,000
purchases of equity securities																																				-3,000,000	-15,000,000	-12,000,000	-21,000,000	-7,000,000	-10,000,000	-34,000,000	-7,000,000	-30,000,000	-20,000,000	-42,000,000	-7,000,000	-22,000,000	-106,000,000	-134,000,000	-77,000,000	-56,000,000	-60,000,000	-30,000,000	-67,000,000	-4,000,000	333,000,000	-596,000,000	-122,000,000	-178,000,000	-160,000,000	-22,000,000	-260,000,000	-253,000,000	-82,000,000	-30,000,000	-52,000,000	-78,000,000	-80,000,000	-71,000,000	-168,000,000	-198,000,000	-215,000,000	-233,000,000
proceeds from sales of equity securities																																				11,000,000	42,000,000	19,000,000	7,000,000	18,000,000	25,000,000	128,000,000	126,000,000	87,000,000	103,000,000	25,000,000	391,000,000	70,000,000	294,000,000	146,000,000	104,000,000	28,000,000	73,000,000	40,000,000	69,000,000	33,000,000	-462,000,000	582,000,000	26,000,000	140,000,000	49,000,000	101,000,000	259,000,000	219,000,000	273,000,000	36,000,000	162,000,000	151,000,000	204,000,000	61,000,000	381,000,000	300,000,000	231,000,000	285,000,000
origination of mortgage loans																																				-20,000,000	-61,000,000	-48,000,000	-31,000,000	-6,000,000	-81,000,000	-31,000,000	-17,000,000	-56,000,000
depreciation																																					19,000,000	20,000,000	20,000,000	21,000,000	19,000,000	19,000,000	18,000,000	19,000,000	20,000,000	21,000,000	23,000,000	21,000,000	21,000,000	21,000,000	18,000,000	18,000,000	18,000,000	15,000,000	13,000,000	11,000,000	12,000,000	12,000,000	13,000,000	13,000,000	14,000,000	14,000,000	17,000,000	22,000,000	17,000,000	19,000,000
cash-continuing operations																																					41,000,000	59,000,000	-9,000,000	0	3,000,000	81,000,000	-5,000,000	10,000,000	-23,000,000	95,000,000	12,000,000	30,000,000	4,000,000	94,000,000	-54,000,000	132,000,000	0	-11,000,000	91,000,000	0	2,000,000	96,000,000
cash-discontinued operations																																																			0	9,000,000	5,000,000	-21,000,000	23,000,000	4,000,000	29,000,000	5,000,000
cash-total																																					41,000,000	59,000,000	-9,000,000	0	3,000,000	81,000,000	-5,000,000	10,000,000	-23,000,000	95,000,000	12,000,000	30,000,000	4,000,000	94,000,000	-54,000,000	141,000,000	5,000,000	-32,000,000	114,000,000	4,000,000	31,000,000	101,000,000
dispositions																																											1,000,000	0												0	9,000,000	-2,000,000	45,000,000	0	0	12,000,000	0	16,000,000			468,000,000	-2,000,000			-254,000,000	5,000,000	0	71,000,000
effect of foreign exchange rate changes on cash-continuing operations																																								-3,000,000	0	2,000,000			0	-2,000,000	2,000,000	3,000,000	7,000,000	-2,000,000	0	-1,000,000
net cash flows provided (used) by operating activities-continuing operations
(income) income from discontinued operations																																									0	1,000,000					0	1,000,000			-2,000,000	1,000,000			-2,000,000	-6,000,000	2,000,000	6,000,000
(gain) loss on disposal of property and equipment																																										9,000,000
dividends paid to loews for 2008 senior preferred
principal payments on debt																																											0	-100,000,000							0	-150,000,000				-21,000,000			-61,000,000	0	-493,000,000	-14,000,000		-1,000,000	-530,000,000	-6,000,000	-249,000,000	-3,000,000	-6,000,000	-129,000,000
policyholders’ investment contract net deposits																																											2,000,000	-2,000,000	-4,000,000	-2,000,000
payments to redeem 2008 senior preferred
proceeds from the issuance of 2008 senior preferred
net cash flows provided (used) by financing activities-continuing operations
net cash flows provided (used) by financing activities-total
cash flows from operating activities:
net realized investment losses, net of participating policyholders’ interests																																															-72,000,000	100,000,000
undistributed losses (earnings) of equity method investees																																																			-34,000,000	70,000,000
net amortization of investment discount																																															-29,000,000
prepaid reinsurance premiums																																															35,000,000	17,000,000	15,000,000	-18,000,000	2,000,000	-22,000,000	43,000,000	9,000,000	-31,000,000	21,000,000	52,000,000	-100,000,000	574,000,000	52,000,000	53,000,000	109,000,000	-98,000,000	106,000,000	122,000,000	103,000,000
federal income taxes recoverable/payable																																																			-50,000,000	72,000,000	26,000,000	-121,000,000	60,000,000	35,000,000	2,000,000	116,000,000
reinsurance balances payable																																															-58,000,000	-11,000,000	6,000,000	28,000,000	-23,000,000	-5,000,000	-45,000,000	-49,000,000	38,000,000	-771,000,000	38,000,000	-17,000,000	-1,013,000,000	-133,000,000	-185,000,000	-13,000,000	-60,000,000	-53,000,000	-171,000,000	-71,000,000
cash flows from investing activities:
change in collateral on loaned securities and derivatives																																															0	0	-40,000,000	35,000,000	-878,000,000	815,000,000							-1,239,000,000	1,025,000,000	-130,000,000	193,000,000	802,000,000	-107,000,000	-148,000,000	-71,000,000	-439,000,000	-105,000,000	566,000,000	-133,000,000	-455,000,000	-1,064,000,000	1,100,000,000	48,000,000
cash flows from financing activities:
return of investment contract account balances																																															-5,000,000	0	-2,000,000	-8,000,000	-285,000,000	-14,000,000	-2,000,000	-11,000,000	-46,000,000	-103,000,000	-63,000,000	-344,000,000
receipts on investment contract account balances																																															1,000,000	1,000,000	1,000,000	1,000,000
net cash transactions from discontinued operations to continuing operations																																																					4,000,000			0	1,000,000	-16,000,000
deferred income tax provision																																																					-33,000,000	-13,000,000	20,000,000	124,000,000	-2,000,000	41,000,000	-183,000,000	83,000,000	-132,000,000	12,000,000	77,000,000	-25,000,000	60,000,000	-77,000,000
undistributed (earnings) losses of equity method investees
federal income taxes recoverable																																																69,000,000	-188,000,000	-21,000,000
net amortization of bond discount																																																	-57,000,000	-58,000,000
net cash flows used by financing activities-discontinued operations
realized investment losses, net of participating policyholders’ interests																																																		532,000,000
undistributed losses of equity method investees																																																		104,000,000
minority interest																																																			12,000,000	12,000,000	16,000,000	11,000,000	10,000,000	13,000,000	10,000,000	9,000,000	8,000,000	11,000,000	-2,000,000	7,000,000	8,000,000	6,000,000	7,000,000	6,000,000
trading securities activity																																																			288,000,000	63,000,000	0	-38,000,000	-6,000,000
realized investment losses, net of participating policyholders’ and minority interests																																																			111,000,000	51,000,000	57,000,000									19,000,000				458,000,000
net amortization of bond (discount) premium																																																			-72,000,000	-65,000,000	-63,000,000	-76,000,000	-56,000,000
dividends paid to stockholders																																																			-40,000,000	-41,000,000	-27,000,000
receipts of investment contract account balances																																																			1,000,000	1,000,000	1,000,000	0	1,000,000	1,000,000	0	1,000,000
net cash flows from financing activities-discontinued operations
undistributed earnings of equity method investees																																																					7,000,000	-57,000,000	-24,000,000	-26,000,000	-29,000,000	-15,000,000
change in collateral on loaned securities																																																					-3,016,000,000	185,000,000	63,000,000	1,044,000,000	-448,000,000	1,022,000,000
net cash flows from investing activities-discontinued operations, including proceeds from disposition																																																					-8,000,000
proceeds from the issuance of long-term debt																																																								747,000,000
payment to repurchase series h issue preferred stock
proceeds from the issuance of common stock
realized investment (gains) losses, net of participating policyholders’ and minority interests																																																							21,000,000	-21,000,000	98,000,000	-9,000,000
gain on disposal of property and equipment																																																											8,000,000
trading securities																																																								60,000,000	64,000,000	267,000,000
stock options exercised by officers																																																								2,000,000	1,000,000	1,000,000
amortization of bond (discount) premium																																																									-90,000,000	-62,000,000	-69,000,000	-29,000,000	-33,000,000	-22,000,000
bad debt benefit from insurance and reinsurance receivables																																																											-23,000,000
purchases of mortgage loans and real estate
issuance of preferred stock
proceeds from issuance of debt
realized investment gains/losses, net of participating policyholders’ and minority interests																																																												-67,000,000
equity method income																																																												-74,000,000	-36,000,000	-80,000,000		-27,000,000	-32,000,000	-75,000,000
federal income taxes payable/recoverable																																																												-427,000,000	239,000,000	-23,000,000		-39,000,000	403,000,000	108,000,000
net purchases of trading securities																																																												-36,000,000	-7,000,000	36,000,000	-3,000,000	2,000,000	0	-4,000,000
proceeds from issuance of surplus notes																																																																0	0	346,000,000
returns and deposits of policyholder account balances on investment contracts																																																																0	4,000,000	6,000,000
cash, beginning of period																																																												0	0	95,000,000		0	0	139,000,000
supplemental disclosures of cash flow information:
cash paid
interest																																																												14,000,000	58,000,000	14,000,000		105,000,000	41,000,000	16,000,000
federal income taxes																																																												288,000,000	-63,000,000	64,000,000		6,000,000	-461,000,000	-79,000,000
period ended september 30
less: undeclared preferred stock dividend																																																												1,000,000	-1,000,000	-17,000,000
net income available to common stockholders																																																												-284,000,000	109,000,000	161,000,000
weighted-average outstanding common stock and common stock equivalents																																																												0	0	256,000,000
effect of dilutive securities, employee stock options
adjusted weighted-average outstanding common stock and common stock equivalents assuming conversions																																																												0	0	256,000,000
basic and diluted earnings per share available to common stockholders																																																												-1,120,000	430,000	630,000
change in bad debt expense (recovery) for insurance and reinsurance receivables
period ended june 30
change in bad debt benefit from insurance and reinsurance receivables																																																														-7,000,000		127,000,000	-90,000,000	33,000,000
non-cash transactions:
notes receivable for the issuance of common stock
earnings per share
for the three months ended march 31																																																														2,005,000,000
cumulative effect of change in accounting principles, net of tax
changes in bad debt benefit from insurance and reinsurance receivables
equity method (income) loss
realized income from discontinued operations, net of tax
•
realized investment gains, net of participating policyholders’ and minority interests																																																																62,000,000
accretion/amortization of bond discount
net cash flows from financing activities
cash paid:
assets
investments:
fixed maturity securities, available-for-sale																																																																12,000,000	-338,000,000	1,220,000,000
fixed maturity securities, trading																																																																-88,000,000	101,000,000	304,000,000
short term investments, available-for-sale																																																																14,000,000	-45,000,000	55,000,000
short term investments, trading																																																																60,000,000	-99,000,000	414,000,000
total investments																																																																-16,000,000	-332,000,000	2,416,000,000
receivables for securities sold																																																																87,000,000	-14,000,000	97,000,000
total assets																																																																70,000,000	-349,000,000	2,527,000,000
liabilities
liabilities:
insurance reserves:
claim and claim adjustment expense																																																																	0	1,000,000
future policy benefits																																																																-5,000,000	-87,000,000	617,000,000
policyholders’ funds																																																																-13,000,000	-101,000,000	1,324,000,000
collateral on loaned securities and derivatives																																																																		17,000,000
payables for securities purchased																																																																73,000,000	44,000,000	43,000,000
total liabilities																																																																42,000,000	-143,000,000	2,049,000,000
amortization of bond discount																																																																	0	1,000,000
adjustments to reconcile net income to net cash flows used by operating activities:
net cash flows provided (used) by operating activities																																																																						45,000,000	233,000,000	372,000,000
proceeds from sales of property and equipment
acquisitions, net of cash acquired
issuance of common stock
return of policyholder account balances on investment contracts																																																																			43,000,000	-5,000,000	-6,000,000	-7,000,000		-10,000,000	-13,000,000	-13,000,000
receipts from investment contracts credited to policyholder account balances
net change in cash and cash equivalents																																																																				38,000,000	-26,000,000	40,000,000		114,000,000	51,000,000	-48,000,000
cash and cash equivalents, beginning of period																																																																				0	0	126,000,000
cash and cash equivalents, end of period																																																																				38,000,000	-26,000,000	166,000,000		114,000,000	51,000,000	94,000,000
(a) see note t.
cumulative effects of changes in accounting principles, net of tax
loss on disposals of property and equipment
amortization of intangibles
sales of property and equipment
net cash flows (used) provided by financing activities
cash and cash equivalents, beginning of year																																																																								0	0	142,000,000
the accompanying notes are an integral part of these condensed consolidated financial statements (unaudited).
3
net cash flows (used) by financing activities
net cash flows used by operating activities																																																																										-78,000,000
net cash flows used by operating activities:
net cash flows from investing activities:
net cash flows from financing activities:
redemption of preferred stock
dividends paid to preferred stockholders

We provide you with 20 years of cash flow statements for CNA Financial stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of CNA Financial stock. Explore the full financial landscape of CNA Financial stock with our expertly curated income statements.

The information provided in this report about CNA Financial stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.